JCR Pharmaceuticals Co., Ltd. appoints Junichi Ando as Director, Regulatory Affairs Department effective from July 1, 2023, Tatsuyoshi Yamamoto as Director, Domestic Development Unit, Development Division, Sairei So as Director, International Development Unit, Development Division and Masaaki Usui Director, New Global Business Operations, Corporate Strategy Division effective from August 1, 2023).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
579 JPY | +3.95% | +0.35% | -50.60% |
May. 31 | JCR Pharmaceuticals' Full-Year Profit Up 46% | MT |
May. 27 | Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 560 Yen From 1,200 Yen, Keeps at Hold | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.60% | 444M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.83% | 248B | |
-1.92% | 219B | |
+10.99% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- 4552 Stock
- News JCR Pharmaceuticals Co., Ltd.
- Jcr Pharmaceuticals Co., Ltd. Announces Executive Changes